Organization

Duke Cancer Center

2 abstracts

Abstract
A prospective trial of apalutamide and abiraterone acetate plus prednisone in Black and White men with metastatic castrate-resistant prostate cancer.
Org: Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University School of Medicine, Department of Head and Neck Surgery & Communication Sciences, Durham, NC, Virginia Oncology Associates, U.S. Oncology Research, Barbara Ann Karmanos Cancer Institute,